Back to explore
Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity
1 Assessments
0 Serious · 1 Some · 0 No · 0 N/A
| Reviewer | Date | Q1.1Does the study have an associated retraction? | Q1.2Does the study have an associated expression of concern or other relevant post-publication notice? | Q1.3Do other studies by the research team highlight causes for concern? | Q2.2Are there concerns relating to the timing or absence of study registration? | Overall | Actions |
|---|---|---|---|---|---|---|---|
| RV007 Professor of Health Services Research | 5 Nov 2025 | No | No | No | Unclear | Some concerns | View |
Publication Details
Journal
Trials
Publisher
Springer Science and Business Media LLC
Published
17 Apr 2025
ISSN / eISSN
1745-6215